Dr. Elad Jacoby is Head of Cell Therapy for Pediatric Hematology and Oncology at Sheba Medical Center, Israel, and Senior Lecturer at Tel Aviv University. A board-certified pediatric hematologist-oncologist, he leads clinical trials in advanced cellular therapies, including CAR T-cell and mitochondrial augmentation for children with cancer and mitochondrial disease. Dr. Jacoby completed fellowships at Johns Hopkins and the National Cancer Institute and is an expert in translating cell therapies from bench to bedside.
